Product Introduction:
Unitrax Tz 1000/125 mg Injection is a combination antibiotic formulation designed to treat a wide range of serious bacterial infections. It combines piperacillin, a broad-spectrum penicillin antibiotic, with tazobactam, a beta-lactamase inhibitor that helps overcome bacterial resistance, in a synergistic 8:1 ratio.
Composition:
- Each vial contains 1000 mg of piperacillin and 125 mg of tazobactam.
- Manufactured with pharmaceutical-grade excipients to ensure optimal stability and bioavailability.
Uses:
- Indicated for the treatment of severe bacterial infections, including:
- Intra-abdominal infections
- Skin and soft tissue infections
- Respiratory tract infections
- Urinary tract infections
- Often administered in hospital settings for patients with complicated infections caused by beta-lactamase-producing bacteria.
Benefits:
- Provides broad-spectrum antibacterial activity by combining the bactericidal effects of piperacillin with the beta-lactamase inhibiting action of tazobactam.
- Enhances clinical efficacy against resistant bacterial strains.
- Can lead to rapid improvement in infection-related symptoms when used as part of a comprehensive treatment plan.
Side Effects:
- Common side effects may include gastrointestinal disturbances such as nausea, vomiting, or diarrhea, and injection site reactions.
- Hypersensitivity reactions, including rash or anaphylaxis, may occur in susceptible individuals.
- Rare cases of antibiotic-associated colitis have been reported; consult a healthcare provider if severe or persistent symptoms develop.
Safety Advice:
- Use Unitrax Tz Injection strictly as prescribed by your healthcare provider.
- Confirm that the patient does not have a known allergy to penicillins or beta-lactam antibiotics.
- Administer under proper medical supervision with appropriate monitoring, especially in patients with renal impairment.
- Store according to the manufacturer’s guidelines, typically at controlled room temperature, and keep out of reach of children.
Unitrax Tz 1000/125 mg Injection offers an effective treatment option for serious bacterial infections, leveraging the synergistic action of piperacillin and tazobactam to overcome resistance and ensure optimal therapeutic outcomes.
